News25/Ratings0
Price$1.02-0.05 (-4.21%)
02:45 PM06:30 PM
News · 26 weeks22+33%
2026-04-192026-10-11
Mix1090d
- Other4(40%)
- Insider4(40%)
- SEC Filings2(20%)
Latest news
25 items- INSIDERSEC Form 4 filed by Director Vnook Stella4 - FIREFLY NEUROSCIENCE, INC. (0000803578) (Issuer)
- INSIDERSEC Form 4 filed by Director Posner Brian M4 - FIREFLY NEUROSCIENCE, INC. (0000803578) (Issuer)
- INSIDERSEC Form 4 filed by Director Menawat Arun Swarup4 - FIREFLY NEUROSCIENCE, INC. (0000803578) (Issuer)
- PRFirefly (NASDAQ: AIFF) and NeuroSigma Partner to Expand Access to First FDA-Cleared, Non-Drug Treatment for Pediatric ADHD– Partnership will introduce NeuroSigma’s second-generation Monarch eTNS® System to Firefly’s nationwide network of Evoke™ clinicians – – Collaboration brings together an FDA-cleared pediatric ADHD treatment and Firefly’s objective brain-function assessment platform and AI-driven ADHD biomarker research – – Monarch offers an at-home, non-medication treatment option for eligible children ages 7 through 12 –– KENMORE, N.Y. and LOS ANGELES, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly") (NASDAQ:AIFF), an artificial intelligence ("AI") company advancing precision neuroscience, and NeuroSigma, Inc. ("NeuroSigma"), a bioelectronic medical device company, today annou
- PRFirefly Neuroscience’s Evoke™ Platform Selected to Bring Objective Brain-Function Insights to Radial’s AI-Native Operating System for Brain Medicine– This integration of Firefly’s FDA 510(k)-cleared, AI-powered EEG/ERP technology follows Radial’s August 2026 acquisition of the management services organization supporting Mindful Health Solutions, forming the country’s largest brain medicine clinical network – KENMORE, N.Y. and NEW YORK, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly") (NASDAQ:AIFF) today announced a strategic collaboration with Radial, operator of the country’s largest network of brain medicine clinics, to pursue the integration of Firefly’s FDA 510(k)-cleared, AI-powered Evoke™ EEG/ERP platform with RadialOS, Radial’s proprietary AI-native operating system for brain medicine. The planned int
- INSIDERSEC Form 3 filed by new insider Paz Jessica Lucia3 - FIREFLY NEUROSCIENCE, INC. (0000803578) (Issuer)
- SECFirefly Neuroscience Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)
- SECFirefly Neuroscience Inc. filed SEC Form 8-K: Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)
- PRFirefly Neuroscience (NASDAQ: AIFF) Reports 291% Increase in TMS Center Customer Brain Scan VolumesKENMORE, N.Y., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly" or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company advancing precision neuroscience, today announced a close to four-fold (291%) year-over-year increase in Transcranial Magnetic Stimulation ("TMS") center customer clinical assessments using its U.S. Food and Drug Administration ("FDA") 510(k)-cleared, AI-powered EEG/ERP platform, Evoke™. By combining qEEG and ERP, Evoke™ provides a more complete view of brain activity, designed to help clinicians identify patterns, differentiate conditions when symptoms overlap, and evaluate brain function with greater clarity. Within the TMS cen
- PRFirefly Neuroscience (NASDAQ: AIFF) and Next Health Launch Precision Cognitive Health Initiative as FDA Advisory Committee’s Recommendation Backs Broader Access to Key Neuroprotective Peptides– FDA Advisory Committee voted to recommend easing compounding restrictions for six peptides, including Epitalon and Semax, late last week – – These two peptides have attracted growing scientific interest for their potential neuroprotective and cognitive-supportive properties – – Collaboration represents a significant step toward making precision cognitive care more measurable, scalable, and clinically actionable – KENMORE, N.Y. and LOS ANGELES, July 28, 2026 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company advancing precision neuroscience, and Next Health, a global leader in health optimization and longevity, today
- SECSEC Form DEF 14A filed by Firefly Neuroscience Inc.DEF 14A - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)
- SECSEC Form 424B3 filed by Firefly Neuroscience Inc.424B3 - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)
- SECSEC Form EFFECT filed by Firefly Neuroscience Inc.EFFECT - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)
- SECSEC Form PRE 14A filed by Firefly Neuroscience Inc.PRE 14A - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)
- SECFirefly Neuroscience Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Financial Statements and Exhibits8-K - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)
- SECAmendment: SEC Form S-3/A filed by Firefly Neuroscience Inc.S-3/A - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)
- SECFirefly Neuroscience Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)
- PRFirefly's AI-Driven Evoke System Powers Discovery of Novel Electrophysiological Biomarker for PTSD– Comes just weeks after Firefly confirmed its active public-private partnership with the U.S. Department of War – KENMORE, N.Y, June 02, 2026 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly" or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company advancing precision neuroscience, today announced the identification of a novel electrophysiological biomarker for Post-Traumatic Stress Disorder ("PTSD") using brain scans collected on its FDA-510(k)-cleared Evoke System. The biomarker discovery emanates partly from Firefly's previously announced public-private partnership with the U.S. Department of War ("DoW") to support the assessment and treatment of active-duty
- SECSEC Form S-8 filed by Firefly Neuroscience Inc.S-8 - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)
- SECSEC Form S-3 filed by Firefly Neuroscience Inc.S-3 - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)
- SECFirefly Neuroscience Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)
- SECFirefly Neuroscience Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)
- SECSEC Form D filed by Firefly Neuroscience Inc.D - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)
- PRWith Brain Scan Volume Momentum Accelerating, Firefly Makes History by Building the World's First Known 200,000+ Standardized EEG/ERP Depository- Firefly's total brain scan volumes have increased sequentially by higher percentages in each of the past four quarters - - Firefly is harnessing increased data and NVIDIA L40S GPU acceleration to power next-generation EEG/ERP processing, enabling new AI-driven biomarker discovery capabilities – - Milestone supports Firefly's goal of building and launching the world's first EEG/ERP-based foundation model of the human brain - KENMORE, N.Y., April 13, 2026 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly" or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and
- SECSEC Form 10-K filed by Firefly Neuroscience Inc.10-K - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)
AIFF FAQ
4 questionsWhere does AIFF stock trade?
Firefly Neuroscience Inc. (AIFF) is listed on NASDAQ.What sector and industry is AIFF in?
Firefly Neuroscience Inc. operates in the Technology sector, Computer Software: Prepackaged Software industry.What companies are similar to AIFF?
Notable peers in the same industry include MSFT (Microsoft Corporation), ORCL (Oracle Corporation), SAP (SAP SE), CRWD (CrowdStrike Holdings Inc.), CRM (Salesforce Inc.). Compare AIFF side-by-side with any of them on Quantisnow.How can I track AIFF on Quantisnow?
Quantisnow aggregates Firefly Neuroscience Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow AIFF to receive live email and push alerts on every new disclosure.